2023-504855-28-00已完成1 期
A Phase 1, Open-label, Multicenter Study of the Safety, Pharmacokinetics, and Pharmacodynamics of MK-4464 as Monotherapy and in Combination with Pembrolizumab in Participants with Advanced/Metastatic Solid Tumors
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 30
- 试验地点
- 2
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（65+ Years, 18-64 Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Konstantin Dobrenkov
Scientific
Merck Sharp & Dohme LLC
研究点 (2)
Loading locations...
相似试验
尚未招募
不适用
A Phase 1, Open-label, Multicenter Study of the Safety, Pharmacokinetics, and Pharmacodynamics of MK-4464 as Monotherapy and in Combination with Pembrolizumab in Participants with Advanced / Metastatic Solid Tumorsadvanced or metastatic solid tumorssolid neoplasm10027656NL-OMON53771Merck Sharp & Dohme (MSD)30
进行中（未招募）
1 期
Study of the safety, tolerability, processing by the body, and ability to provoke immune system response of ocular injections of RO7446603 alone and in combination with aflibercept or faricimab in participants with diabetic macular edemaDiabetic macular edema (DME)Eye DiseasesISRCTN14152148Genentech, Inc.75
进行中（未招募）
不适用
A study to observe the long-term safety of GS-9137 (which is one of a new class of antiretroviral medications called integrase inhibitors) given with ritonavir, in combination with other antiretroviral agents in subjects who have completed a prior GS-9137/ritonavir (GS-9137/r) study for the treatment of HIV-1 infection.Human Immunodeficiency Virus (HIV-1) InfectionMedDRA version: 17.1Level: LLTClassification code 10068341Term: HIV-1 infectionSystem Organ Class: 100000004862EUCTR2007-004736-23-Outside-EU/EEAGilead Sciences Inc.1,000
进行中（未招募）
1 期
A 52-Week, Open-label, Multicenter Study of the Safety and Tolerabilityof Aripiprazole Flexibly Dosed in the Treatment of Children andAdolescents with Autistic DisorderAutistic disorderEUCTR2017-000175-86-Outside-EU/EEAOtsuka Pharmaceutical Development & Commercialization,330
进行中（未招募）
不适用
A global study to see how safe and effective a Once-weekly tablet containing Aripiprazole is in Children and Adolecents with Tourette's DisorderTourette’s DisorderMedDRA version: 16.0Level: PTClassification code 10044126Term: Tourette's disorderSystem Organ Class: 10010331 - Congenital, familial and genetic disordersEUCTR2011-000469-11-BGOtsuka Pharmaceutical Development & Commercialization, Inc.156